Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.
作者信息
Eckert Alexander J, Mader Julia K, Altmeier Marcus, Mühldorfer Steffen, Gillessen Anton, Dallmeier Dhayana, Shah Viral N, Heyer Christoph, Hartmann Bettina, Holl Reinhard W
机构信息
Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany; German Centre for Diabetes Research (DZD), Neuherberg, Germany.
Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
出版信息
J Diabetes Complications. 2020 Oct;34(10):107664. doi: 10.1016/j.jdiacomp.2020.107664. Epub 2020 Jun 27.
Abstract
摘要
相似文献
1
Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.
J Diabetes Complications. 2020 Oct;34(10):107664. doi: 10.1016/j.jdiacomp.2020.107664. Epub 2020 Jun 27.
2
Distinct trajectories of HbA in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approach.
Diabet Med. 2019 Nov;36(11):1468-1477. doi: 10.1111/dme.14103. Epub 2019 Sep 23.
3
Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i).
Curr Med Res Opin. 2019 Sep;35(9):1607-1614. doi: 10.1080/03007995.2019.1605160. Epub 2019 May 3.
4
Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.
J Bone Miner Res. 2019 Nov;34(11):2045-2051. doi: 10.1002/jbmr.3826. Epub 2019 Oct 9.
5
Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes.
Endocr J. 2018 Apr 26;65(4):461-467. doi: 10.1507/endocrj.EJ17-0440. Epub 2018 Feb 20.
6
Relationship Between HbA1c Level and Effectiveness of SGLT2 Inhibitors in Decompensated Heart Failure Patients with Type 2 Diabetes Mellitus.
Int Heart J. 2021 Jul 30;62(4):843-849. doi: 10.1536/ihj.20-764. Epub 2021 Jul 17.
7
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17.
8
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin.
Cardiovasc Diabetol. 2021 Jul 31;20(1):160. doi: 10.1186/s12933-021-01352-0.
9
Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium-glucose cotransporter 2 inhibitor: a retrospective database study.
Curr Med Res Opin. 2020 Oct;36(10):1583-1589. doi: 10.1080/03007995.2020.1816945. Epub 2020 Sep 11.
10
Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis.
J Am Heart Assoc. 2020 Apr 7;9(7):e015323. doi: 10.1161/JAHA.119.015323. Epub 2020 Mar 30.
引用本文的文献
1
Association between haemoglobin A1c level and hip fracture risk in type 2 diabetes patients: A systematic review and meta-analysis.
J Clin Orthop Trauma. 2025 May 10;67:103040. doi: 10.1016/j.jcot.2025.103040. eCollection 2025 Aug.
2
Predictors of Fracture in Middle-Aged and Older Adults With Type 2 Diabetes and Overweight or Obesity.
J Clin Endocrinol Metab. 2025 May 19;110(6):e1911-e1933. doi: 10.1210/clinem/dgae623.
3
Bone Marrow Adiposity Alterations in Type 2 Diabetes Are Sex-Specific and Associated with Serum Lipid Levels.
J Bone Miner Res. 2023 Dec;38(12):1877-1884. doi: 10.1002/jbmr.4931. Epub 2023 Nov 16.
4
Risk Factors for Incident Fracture in Older Adults With Type 2 Diabetes: The Framingham Heart Study.
Diabetes Care. 2021 Jul;44(7):1547-1555. doi: 10.2337/dc20-3150. Epub 2021 May 17.
本文引用的文献
1
Trends in Emergency Department Visits and Inpatient Admissions for Hyperglycemic Crises in Adults With Diabetes in the U.S., 2006-2015.
Diabetes Care. 2020 May;43(5):1057-1064. doi: 10.2337/dc19-2449. Epub 2020 Mar 11.
2
Both hypo- and hyperglycaemia are associated with increased fracture risk in Japanese people with type 2 diabetes: the Fukuoka Diabetes Registry.
Diabet Med. 2020 May;37(5):838-847. doi: 10.1111/dme.14142. Epub 2019 Oct 19.
3
Bone health in diabetes and prediabetes.
World J Diabetes. 2019 Aug 15;10(8):421-445. doi: 10.4239/wjd.v10.i8.421.
4
OSTEOPOROSIS AND FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):231-236. doi: 10.4183/aeb.2019.231.
5
Relationships of social support, health-promoting lifestyles, glycemic control, and bone turnover among adults with type 2 diabetes.
Jpn J Nurs Sci. 2020 Jan;17(1):e12280. doi: 10.1111/jjns.12280. Epub 2019 Jul 8.
6
Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus.
J Bone Miner Res. 2019 Nov;34(11):2045-2051. doi: 10.1002/jbmr.3826. Epub 2019 Oct 9.
7
The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies.
Obes Rev. 2019 Oct;20(10):1494-1503. doi: 10.1111/obr.12885. Epub 2019 Jun 28.
8
Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.
Osteoporos Int. 2019 Oct;30(10):1923-1940. doi: 10.1007/s00198-019-04968-x. Epub 2019 May 27.
9
Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta-analysis.
Diabetes Metab Res Rev. 2019 Oct;35(7):e3170. doi: 10.1002/dmrr.3170. Epub 2019 May 15.
10
Glycemic control and 10-year odds of all-cause fractures in elderly veterans with type 2 diabetes.
Diabetes Res Clin Pract. 2019 May;151:46-55. doi: 10.1016/j.diabres.2019.03.027. Epub 2019 Mar 20.
Zotero 插件